Literature DB >> 15247977

Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.

Shosaku Nomura1, Akira Shouzu, Seitaro Omoto, Mitsushige Nishikawa, Toshiji Iwasaka, Shirou Fukuhara.   

Abstract

Endothelial cells, platelets, and oxidized LDL could play very important roles in the development of atherosclerosis in diabetes patients. The levels of plasma endothelial cell-derived microparticles (EDMP), platelet-derived microparticles (PDMP), platelet-P-selectin (plt-PS), soluble CD40 ligand (sCD40L), and anti-oxidized LDL antibody were measured and compared to develop a better understanding of their potential contribution to diabetic vascular complications. The concentrations of EDMP, PDMP, plt-PS, and sCD40L in diabetic patients were significantly higher than those in normal subjects. The number of EDMPs in patients with diabetes complicated by nephropathy was significantly higher than that in those without complications. Levels of anti-oxidized LDL antibody were also higher in type 2 diabetic patients than in control subjects. In addition, anti-oxidized LDL antibody levels correlated with EDMP, PDMP, plt-PS, and sCD40L levels in nephropathy patients. In the nephropathy group treated with sarpogrelate hydrochrolide, a 5-HT(2A) receptor antagonist, EDMP, PDMP, plt-PS, and sCD40L levels were decreased significantly. Oxidized LDL increased expression of plt-PS, and also promoted shedding of PDMP. Furthermore, oxidized LDL promoted a dose-dependent release of 5-hydroxytriptamine. On the other hand, activated platelets and PDMP promoted endothelial cells and THP-1 (monocytic cell line) interaction, and membrane vesiculation occurred in the presence of oxidized LDL. These findings suggest that activated platelets and oxidized LDL induce EDMP generation, and that elevated EDMPs may be a sign of vascular complications in type 2 diabetic patients, particularly those who suffer from diabetes-associated nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247977     DOI: 10.1177/107602960401000302

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  24 in total

Review 1.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 2.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

3.  Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Authors:  Nicolas Amabile; Susan Cheng; Jean Marie Renard; Martin G Larson; Anahita Ghorbani; Elizabeth McCabe; Gabriel Griffin; Coralie Guerin; Jennifer E Ho; Stanley Y Shaw; Kenneth S Cohen; Ramachandran S Vasan; Alain Tedgui; Chantal M Boulanger; Thomas J Wang
Journal:  Eur Heart J       Date:  2014-04-16       Impact factor: 29.983

Review 4.  Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

Authors:  Ying Wang; Li-ming Chen; Ming-lin Liu
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

5.  Purification of exosome-like vesicles from urine.

Authors:  Christopher Y Chen; Marie C Hogan; Christopher J Ward
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

6.  Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

Authors:  Min-Dan Xu; Xian-Zheng Wu; Yun Zhou; Ying Xue; Ke-Qin Zhang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

Review 7.  Endothelial microparticles: sophisticated vesicles modulating vascular function.

Authors:  Anne M Curtis; Jay Edelberg; Rebecca Jonas; Wade T Rogers; Jonni S Moore; Wajihuddin Syed; Emile R Mohler
Journal:  Vasc Med       Date:  2013-07-26       Impact factor: 3.239

8.  Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.

Authors:  Karthik Balasubramaniam; Girish N Viswanathan; Sally M Marshall; Azfar G Zaman
Journal:  Cardiol Res Pract       Date:  2012-01-05       Impact factor: 1.866

9.  Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect.

Authors:  Kaushik Das; Shiva Keshava; Shabbir A Ansari; Vijay Kondreddy; Charles T Esmon; John H Griffin; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

10.  Comparison of ox-LDL Levels in Diabetic Patients with Normo-, Micro-, and Macroalbuminuria with Their First Degree Relatives and the Healthy Control Group.

Authors:  Parisa Behzadi; Firouzeh Torabi; Massoud Amini; Ashraf Aminorroaya
Journal:  Int J Endocrinol       Date:  2012-11-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.